Cargando…
Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing
Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assay...
Autores principales: | Fischer, Peter U., Fischer, Kerstin, Curtis, Kurt C., Huang, Yuefang, Fetcho, Nicole, Goss, Charles W., Weil, Gary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437184/ https://www.ncbi.nlm.nih.gov/pubmed/34181574 http://dx.doi.org/10.4269/ajtmh.20-1390 |
Ejemplares similares
-
IgG(4) antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis
por: Greene, Sarah E., et al.
Publicado: (2023) -
Laboratory and Field Evaluation of a New Rapid Test for Detecting Wuchereria bancrofti Antigen in Human Blood
por: Weil, Gary J., et al.
Publicado: (2013) -
The application of a lateral flow immunographic assay to rapidly test for dexamethasone in commercial facial masks
por: Wang, Min, et al.
Publicado: (2019) -
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies
por: Wang, Jianfu J., et al.
Publicado: (2021) -
Characterization and localization of antigens for serodiagnosis of human paragonimiasis
por: Curtis, Kurt C., et al.
Publicado: (2021)